CORGENIX LAUNCHES NEXT GENERATION PREDICTIVE CARDIOVASCULAR DIAGNOSTIC LINE
Corgenix Medical Corporation (OTCBB:CONX - News),
a worldwide marketer of diagnostic test kits, announces the launch of AtherOx,
a next generation product line utilizing patented technology to identify individuals
at risk for developing atherosclerotic cardiovascular disease. The AtherOx
technology is a novel diagnostic product that measures oxidized Low-Density
Lipoprotein (oxLDL) complexed with a plasma protein known as B2GP1, which combined
functions as a specific marker of potential cardiovascular disease.